While clinical guidelines used in the Welcome Service remained unchanged from standard-of-care (instead, provided additional tools and training to support guideline uptake), implementation of existing guidance was mixed: half of eligible patients received TB prevention, cotrimoxazole prophylaxis, and CD4 testing at re-engagement. The gene discussed is CD4; the disease is tuberculosis.